SYNBIOTIC SE
NuWays RecommendationRecommendation
Buy
Price Target
€12.40
Upside
287.50%
Chart
- 1M
- 3M
- 6M
- YTD
- 1Y
- 3Y
€3.20
0 (0.00%)
Realtime-Data from 26.08.2025 05:30:19
SYNBIOTIC is a Buy-and-Build operator in the European industrial hemp, cannabis and cannabinoid market with an objective to establish a fully integrated platform-company with activities across the entire value chain from cultivation to production and retail.
ISIN
DE000A3E5A59
Market Cap
€17.92M
Enterprise Value
€20.99M
26 week avg vol.
5599537
Primar Exchange
Xetra
IPO
2019
Sector
Health Care & Pharma
Headquarters
Munich, DE
Employees
75
Incorporated
2015
CEO
Daniel Kruse
Website
Institutional Investors
47.00%
Management
7.60%
Free Float
45.40%
Sep 25
Annual General Meeting
Sep 25
Publication half yearly financial report
KPIs in EUR
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| Sales | 3.86M | 15.92M | 22.99M |
| EBITDA | -7.19M | -1.01M | 1.84M |
| EBIT | -11.75M | -2.13M | 756.62K |
| EPS | -2.12 | -0.30 | 0.06 |
| FCF | -2.94M | -4.33M | 1.35M |
Valuation
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| EV / Sales | 5.44x | 1.30x | 0.84x |
| EV / EBITDA | (2.92x) | (20.43x) | 10.55x |
| EV / EBIT | (1.79x) | (9.73x) | 25.60x |
| Price / Earnings | (1.51x) | (10.51x) | 52.97x |
| EV / FCF | (7.13x) | (4.78x) | 14.31x |
Downloads
Latest Research
Initiation